世界の製薬用超高バリアフィルム市場予測（～2028年）：PET、 CPP、 BOPP、 PVA、 PLA、 その他

• 英文タイトル：Global Pharmaceutical Ultra-high Barrier Films Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E2080 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

製薬用超高バリアフィルム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の製薬用超高バリアフィルムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 製薬用超高バリアフィルム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・PET、 CPP、 BOPP、 PVA、 PLA、 その他 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界の製薬用超高バリアフィルム市場の主要な市場プレーヤーは以下のとおりです。 ・ACG Pharmapack、Amcor Limited、Winpak、The Mondi Group、Berry Global Group、Constantia Flexibles、Glenroy, Inc、Toray Plastics、Cleplast Metallized Products、Schur Flexibles Hoilding GesmbH、ProAmpac LLC.、Bischof and Klein GmbH and Co. KG、Dunmore Corporation、FLAIR Flexible Packaging Corporation 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、製薬用超高バリアフィルム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な製薬用超高バリアフィルムメーカーの企業概要、2019年～2022年までの製薬用超高バリアフィルムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な製薬用超高バリアフィルムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別製薬用超高バリアフィルムの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの製薬用超高バリアフィルムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での製薬用超高バリアフィルム市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および製薬用超高バリアフィルムの産業チェーンを掲載しています。 ・第13、14、15章では、製薬用超高バリアフィルムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：ACG Pharmapack、Amcor Limited、Winpak、The Mondi Group、Berry Global Group、Constantia Flexibles、Glenroy, Inc、Toray Plastics、Cleplast Metallized Products、Schur Flexibles Hoilding GesmbH、ProAmpac LLC.、Bischof and Klein GmbH and Co. KG、Dunmore Corporation、FLAIR Flexible Packaging Corporation ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：PET、 CPP、 BOPP、 PVA、 PLA、 その他 ・用途別分析2017年-2028年：病院、クリニック、その他 ・製薬用超高バリアフィルムの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・製薬用超高バリアフィルムのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・製薬用超高バリアフィルムのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・製薬用超高バリアフィルムの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・製薬用超高バリアフィルムの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Pharmaceutical Ultra-high Barrier Films market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical Ultra-high Barrier Films market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Pharmaceutical Ultra-high Barrier Films global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PET segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pharmaceutical Ultra-high Barrier Films include ACG Pharmapack, Amcor Limited, Winpak, The Mondi Group, and Berry Global Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmaceutical Ultra-high Barrier Films market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PET
CPP
BOPP
PVA
PLA
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Pharmaceutical Ultra-high Barrier Films market are listed below:
ACG Pharmapack
Amcor Limited
Winpak
The Mondi Group
Berry Global Group
Constantia Flexibles
Glenroy, Inc
Toray Plastics
Cleplast Metallized Products
Schur Flexibles Hoilding GesmbH
ProAmpac LLC.
Bischof and Klein GmbH and Co. KG
Dunmore Corporation
FLAIR Flexible Packaging Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Ultra-high Barrier Films product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceutical Ultra-high Barrier Films, with price, sales, revenue and global market share of Pharmaceutical Ultra-high Barrier Films from 2019 to 2022.
Chapter 3, the Pharmaceutical Ultra-high Barrier Films competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Ultra-high Barrier Films breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Ultra-high Barrier Films market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Ultra-high Barrier Films.
Chapter 13, 14, and 15, to describe Pharmaceutical Ultra-high Barrier Films sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Pharmaceutical Ultra-high Barrier Films Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pharmaceutical Ultra-high Barrier Films Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PET
1.2.3 CPP
1.2.4 BOPP
1.2.5 PVA
1.2.6 PLA
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Pharmaceutical Ultra-high Barrier Films Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Pharmaceutical Ultra-high Barrier Films Market Size & Forecast
1.4.1 Global Pharmaceutical Ultra-high Barrier Films Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pharmaceutical Ultra-high Barrier Films Sales in Volume (2017-2028)
1.4.3 Global Pharmaceutical Ultra-high Barrier Films Price (2017-2028)
1.5 Global Pharmaceutical Ultra-high Barrier Films Production Capacity Analysis
1.5.1 Global Pharmaceutical Ultra-high Barrier Films Total Production Capacity (2017-2028)
1.5.2 Global Pharmaceutical Ultra-high Barrier Films Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical Ultra-high Barrier Films Market Drivers
1.6.2 Pharmaceutical Ultra-high Barrier Films Market Restraints
1.6.3 Pharmaceutical Ultra-high Barrier Films Trends Analysis
2 Manufacturers Profiles
2.1 ACG Pharmapack
2.1.1 ACG Pharmapack Details
2.1.2 ACG Pharmapack Major Business
2.1.3 ACG Pharmapack Pharmaceutical Ultra-high Barrier Films Product and Services
2.1.4 ACG Pharmapack Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amcor Limited
2.2.1 Amcor Limited Details
2.2.2 Amcor Limited Major Business
2.2.3 Amcor Limited Pharmaceutical Ultra-high Barrier Films Product and Services
2.2.4 Amcor Limited Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Winpak
2.3.1 Winpak Details
2.3.2 Winpak Major Business
2.3.3 Winpak Pharmaceutical Ultra-high Barrier Films Product and Services
2.3.4 Winpak Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 The Mondi Group
2.4.1 The Mondi Group Details
2.4.2 The Mondi Group Major Business
2.4.3 The Mondi Group Pharmaceutical Ultra-high Barrier Films Product and Services
2.4.4 The Mondi Group Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Berry Global Group
2.5.1 Berry Global Group Details
2.5.2 Berry Global Group Major Business
2.5.3 Berry Global Group Pharmaceutical Ultra-high Barrier Films Product and Services
2.5.4 Berry Global Group Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Constantia Flexibles
2.6.1 Constantia Flexibles Details
2.6.2 Constantia Flexibles Major Business
2.6.3 Constantia Flexibles Pharmaceutical Ultra-high Barrier Films Product and Services
2.6.4 Constantia Flexibles Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Glenroy, Inc
2.7.1 Glenroy, Inc Details
2.7.2 Glenroy, Inc Major Business
2.7.3 Glenroy, Inc Pharmaceutical Ultra-high Barrier Films Product and Services
2.7.4 Glenroy, Inc Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Toray Plastics
2.8.1 Toray Plastics Details
2.8.2 Toray Plastics Major Business
2.8.3 Toray Plastics Pharmaceutical Ultra-high Barrier Films Product and Services
2.8.4 Toray Plastics Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cleplast Metallized Products
2.9.1 Cleplast Metallized Products Details
2.9.2 Cleplast Metallized Products Major Business
2.9.3 Cleplast Metallized Products Pharmaceutical Ultra-high Barrier Films Product and Services
2.9.4 Cleplast Metallized Products Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Schur Flexibles Hoilding GesmbH
2.10.1 Schur Flexibles Hoilding GesmbH Details
2.10.2 Schur Flexibles Hoilding GesmbH Major Business
2.10.3 Schur Flexibles Hoilding GesmbH Pharmaceutical Ultra-high Barrier Films Product and Services
2.10.4 Schur Flexibles Hoilding GesmbH Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 ProAmpac LLC.
2.11.1 ProAmpac LLC. Details
2.11.2 ProAmpac LLC. Major Business
2.11.3 ProAmpac LLC. Pharmaceutical Ultra-high Barrier Films Product and Services
2.11.4 ProAmpac LLC. Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bischof and Klein GmbH and Co. KG
2.12.1 Bischof and Klein GmbH and Co. KG Details
2.12.2 Bischof and Klein GmbH and Co. KG Major Business
2.12.3 Bischof and Klein GmbH and Co. KG Pharmaceutical Ultra-high Barrier Films Product and Services
2.12.4 Bischof and Klein GmbH and Co. KG Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Dunmore Corporation
2.13.1 Dunmore Corporation Details
2.13.2 Dunmore Corporation Major Business
2.13.3 Dunmore Corporation Pharmaceutical Ultra-high Barrier Films Product and Services
2.13.4 Dunmore Corporation Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 FLAIR Flexible Packaging Corporation
2.14.1 FLAIR Flexible Packaging Corporation Details
2.14.2 FLAIR Flexible Packaging Corporation Major Business
2.14.3 FLAIR Flexible Packaging Corporation Pharmaceutical Ultra-high Barrier Films Product and Services
2.14.4 FLAIR Flexible Packaging Corporation Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pharmaceutical Ultra-high Barrier Films Breakdown Data by Manufacturer
3.1 Global Pharmaceutical Ultra-high Barrier Films Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pharmaceutical Ultra-high Barrier Films Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pharmaceutical Ultra-high Barrier Films
3.4 Market Concentration Rate
3.4.1 Top 3 Pharmaceutical Ultra-high Barrier Films Manufacturer Market Share in 2021
3.4.2 Top 6 Pharmaceutical Ultra-high Barrier Films Manufacturer Market Share in 2021
3.5 Global Pharmaceutical Ultra-high Barrier Films Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pharmaceutical Ultra-high Barrier Films Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pharmaceutical Ultra-high Barrier Films Market Size by Region
4.1.1 Global Pharmaceutical Ultra-high Barrier Films Sales in Volume by Region (2017-2028)
4.1.2 Global Pharmaceutical Ultra-high Barrier Films Revenue by Region (2017-2028)
4.2 North America Pharmaceutical Ultra-high Barrier Films Revenue (2017-2028)
4.3 Europe Pharmaceutical Ultra-high Barrier Films Revenue (2017-2028)
4.4 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Revenue (2017-2028)
4.5 South America Pharmaceutical Ultra-high Barrier Films Revenue (2017-2028)
4.6 Middle East and Africa Pharmaceutical Ultra-high Barrier Films Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pharmaceutical Ultra-high Barrier Films Sales in Volume by Type (2017-2028)
5.2 Global Pharmaceutical Ultra-high Barrier Films Revenue by Type (2017-2028)
5.3 Global Pharmaceutical Ultra-high Barrier Films Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pharmaceutical Ultra-high Barrier Films Sales in Volume by Application (2017-2028)
6.2 Global Pharmaceutical Ultra-high Barrier Films Revenue by Application (2017-2028)
6.3 Global Pharmaceutical Ultra-high Barrier Films Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pharmaceutical Ultra-high Barrier Films Sales by Type (2017-2028)
7.2 North America Pharmaceutical Ultra-high Barrier Films Sales by Application (2017-2028)
7.3 North America Pharmaceutical Ultra-high Barrier Films Market Size by Country
7.3.1 North America Pharmaceutical Ultra-high Barrier Films Sales in Volume by Country (2017-2028)
7.3.2 North America Pharmaceutical Ultra-high Barrier Films Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pharmaceutical Ultra-high Barrier Films Sales by Type (2017-2028)
8.2 Europe Pharmaceutical Ultra-high Barrier Films Sales by Application (2017-2028)
8.3 Europe Pharmaceutical Ultra-high Barrier Films Market Size by Country
8.3.1 Europe Pharmaceutical Ultra-high Barrier Films Sales in Volume by Country (2017-2028)
8.3.2 Europe Pharmaceutical Ultra-high Barrier Films Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Sales by Type (2017-2028)
9.2 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Sales by Application (2017-2028)
9.3 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pharmaceutical Ultra-high Barrier Films Sales by Type (2017-2028)
10.2 South America Pharmaceutical Ultra-high Barrier Films Sales by Application (2017-2028)
10.3 South America Pharmaceutical Ultra-high Barrier Films Market Size by Country
10.3.1 South America Pharmaceutical Ultra-high Barrier Films Sales in Volume by Country (2017-2028)
10.3.2 South America Pharmaceutical Ultra-high Barrier Films Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Sales by Type (2017-2028)
11.2 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Sales by Application (2017-2028)
11.3 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pharmaceutical Ultra-high Barrier Films and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pharmaceutical Ultra-high Barrier Films
12.3 Pharmaceutical Ultra-high Barrier Films Production Process
12.4 Pharmaceutical Ultra-high Barrier Films Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pharmaceutical Ultra-high Barrier Films Typical Distributors
13.3 Pharmaceutical Ultra-high Barrier Films Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---